Atezolizumab plus Bevacizumab Versus Lenvatinib for Unresectable Hepatocellular Carcinoma: A Large, Real-Life, Worldwide Population.
AuthID
P-00Z-DPY
P-00Z-DPY
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service